Sleepiz One+ vs. Capnography and Electrocardiography
Launched by SLEEPIZ AG · Aug 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different methods for measuring important health signs: the Sleepiz One+ device and traditional methods like capnography (which measures carbon dioxide in your breath) and electrocardiography (which tracks your heart's rhythm). The goal is to see how well these methods measure breathing and heart rates, especially in people with chronic conditions like asthma, COPD, diabetes, and high blood pressure, as well as in healthy adults. Monitoring these vital signs is important because changes can indicate worsening health, and catching these changes early can lead to better care.
To participate in this study, you need to be at least 18 years old. You can join if you have one or more chronic medical conditions, or if you are a healthy volunteer with no chronic conditions. However, if you have certain medical devices like a pacemaker, are pregnant or breastfeeding, or have difficulty following study procedures, you won't be eligible. Participants will be asked to provide consent and will be monitored in a clinical setting while at rest. This is a great opportunity to contribute to research that could improve monitoring for many patients in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients:
- • Age \>=18years
- • Informed Consent as documented by signature
- • One (or more) chronic medical condition/s (e.g., diabetes, asthma, cardiovascular or respiratory diseases, etc.)
- • Healthy volunteers
- • Age \>=18years
- • Informed Consent as documented by signature
- • No diagnosed chronic medical condition
- Exclusion Criteria:
- • Patients
- • Previous enrolment into the current study,
- • Cardiac pacemaker or another implanted electrical device
- • Women who are pregnant or breastfeeding
- • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
- Healthy volunteers:
- • Previous enrolment into the current study,
- • Cardiac pacemaker or another implanted electrical device
- • Women who are pregnant or breastfeeding
- • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
- • Presence of diagnosed chronic medical condition
About Sleepiz Ag
Sleepiz AG is an innovative healthcare company dedicated to advancing sleep medicine through cutting-edge technology and research. Specializing in the development of non-invasive diagnostic tools, Sleepiz AG focuses on improving the assessment and treatment of sleep disorders. With a commitment to enhancing patient outcomes, the company conducts rigorous clinical trials to validate its solutions, aiming to provide healthcare professionals with reliable, data-driven insights into sleep health. By leveraging its expertise in sleep science and technology, Sleepiz AG strives to transform the landscape of sleep diagnostics and contribute to the overall well-being of individuals affected by sleep-related issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, Zurich, Switzerland
Patients applied
Trial Officials
Christian Neumann, Dr. med.
Principal Investigator
Zentrum für Schlafmedizin "Schlaflabor Fluntern"
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported